Side Effects of Perioperative Intravesical Treatment and Treatment Strategies for These Side Effects

被引：21

作者：

Griffin, Joshua G.

Holzbeierlein, Jeff

机构：

[1] Department of Urology, University of Kansas Medical Center, Kansas City, KS 66160, 3901 Rainbow Boulevard

来源：

UROLOGIC CLINICS OF NORTH AMERICA | 2013年 / 40卷 / 02期

关键词：

SUPERFICIAL BLADDER-CANCER; TRANSITIONAL-CELL CARCINOMA; MITOMYCIN-C INSTILLATION; IMMEDIATE POSTOPERATIVE INSTILLATION; TRANSURETHRAL RESECTION; RENAL TOXICITY; PULMONARY TOXICITY; STAGE-TA; N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE AD-32; PERIVESICAL INFLAMMATION;

D O I：

10.1016/j.ucl.2013.01.005

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Perioperative intravesical chemotherapy has a well-established role in the treatment of non-muscle invasive bladder cancer. There are multiple agents that can be used in this fashion with varying properties. Although chemical cystitis is the most common side effect and is usually self-limiting, significant toxicity can occur with intravesical chemotherapy. It is imperative that the urologist is aware of the acute and delayed side effects of intravesical chemotherapy and how to manage potential complications. Both local and systemic toxicities are discussed, as well as strategies to minimize and manage them.

引用

页码：197 / +

页数：15

共 82 条

[1]

Albanell J, 2000, SEMIN ONCOL, V27, P347

[2]

Ali-El-Dein B, 1997, J UROLOGY, V158, P73

[3] Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): A randomized prospective study [J].

AlielDein, B ;

ElBaz, M ;

Aly, ANM ;

Shamaa, S ;

Ashamallah, A .

JOURNAL OF UROLOGY, 1997, 158 (01) :68-73

[4] BLADDER WALL CALCIFICATION AFTER TOPICAL MITOMYCIN-C [J].

ALTER, AJ ;

MALEK, GH .

JOURNAL OF UROLOGY, 1987, 138 (05) :1239-1240

[5] EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder [J].

Babjuk, Marko ;

Oosterlinck, Willem ;

Sylvester, Richard ;

Kaasinen, Eero ;

Boehle, Andreas ;

Palou-Redorta, Juan .

EUROPEAN UROLOGY, 2008, 54 (02) :303-314

[6] The actual incidence of bladder perforation following transurethral bladder surgery [J].

Balbay, MD ;

Çimentepe, E ;

Ünsal, A ;

Bayrak, Ö ;

Koç, A ;

Akbulut, Z .

JOURNAL OF UROLOGY, 2005, 174 (06) :2260-2262

[7] Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Study [J].

Boehle, Andreas ;

Leyh, Herbert ;

Frei, Christian ;

Kuehn, Michael ;

Tschada, Reinhold ;

Pottek, Tobias ;

Wagner, Walter ;

Knispel, Helmut H. ;

von Pokrzywnitzki, Wolfgang ;

Zorlu, Ferruh ;

Helsberg, Karin ;

Luebben, Birgit ;

Soldatenkova, Victoria ;

Stoffregen, Clemens ;

Buettner, Hartwig .

EUROPEAN UROLOGY, 2009, 56 (03) :495-503

[8] Intravesical mitomycin C for superficial transitional cell carcinoma [J].

Bolenz, Christian ;

Cao, Yanwei ;

Arancibia, Mario Fernandez ;

Trojan, Lutz ;

Allen, Peter ;

Michel, Maurice Stephan .

EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (08) :1273-1282

[9] INTRAVESICAL ADJUVANT CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL-CELL BLADDER-CARCINOMA - RESULTS OF 2 EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER RANDOMIZED TRIALS WITH MITOMYCIN-C AND DOXORUBICIN COMPARING EARLY VERSUS DELAYED INSTILLATIONS AND SHORT-TERM VERSUS LONG-TERM TREATMENT [J].

BOUFFIOUX, C ;

KURTH, KH ;

BONO, A ;

OOSTERLINCK, W ;

KRUGER, CB ;

DEPAUW, M ;

SYLVESTER, R ;

DENIS, L ;

NEWLING, D ;

HALL, R ;

BRESSEL, M ;

CASSELMAN, J ;

SMITH, P ;

ROBINSON, M ;

KEUPPENS, F ;

TOLLEY, D ;

JAKSE, G ;

BOLLACK, C ;

VERGISON, B ;

HOEKSTRA, W ;

DASILVA, FC ;

GROEN, J ;

RICHARDS, B ;

PAVONEMACALUSO, M ;

VANDERMEIJDEN, A ;

ZWARTENDIJK, H ;

JACOBI, G ;

VANCAUBERG, R ;

SCHRODER, F ;

HIRDES, D ;

LEISINGER, H ;

RIEDL, H ;

LUDWIG, P ;

ROOZENDAAL, K ;

MARECHAL, L ;

VANAUBEL, O ;

CONSIDINE, J ;

DEBRUYNE, F ;

CARREIRA, F ;

DEWALL, D ;

MENSINK, H ;

VIGGIANO, G .

JOURNAL OF UROLOGY, 1995, 153 (03) :934-941

[10] Mitomycin C: a clinical update [J].

Bradner, WT .

CANCER TREATMENT REVIEWS, 2001, 27 (01) :35-50

← 1 2 3 4 5 6 7 8 9 →